{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:08:29Z","timestamp":1767650909990,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1124\/jpet.102.037754","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:51:25Z","timestamp":1042224685000},"page":"326-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Investigation of CGRP Receptors and Peptide Pharmacology in Human Coronary Arteries. Characterization with a Nonpeptide Antagonist"],"prefix":"10.1016","volume":"304","author":[{"given":"Philip","family":"Hasbak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Saetrum","family":"Opgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Eskesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Schifter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Longmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.102.037754_bib1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(24)38815-9","article-title":"Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist.","volume":"296","author":"Aiyar","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.037754_bib2","first-page":"48","article-title":"Some quantitative uses of drug antagonists.","volume":"14","author":"Arunlakshana","year":"1959","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.037754_bib3","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1210\/endo.140.6.6783","article-title":"A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.","volume":"140","author":"Buhlmann","year":"1999","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.102.037754_bib4","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.037754_bib5","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-3565(25)20868-0","article-title":"Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity.","volume":"251","author":"Dennis","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.037754_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","article-title":"Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.","volume":"129","author":"Doods","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.037754_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(01)01532-1","article-title":"Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells.","volume":"434","author":"Edvinsson","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.037754_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00934-1","article-title":"Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries.","volume":"415","author":"Edvinsson","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.037754_bib9","doi-asserted-by":"crossref","first-page":"31438","DOI":"10.1074\/jbc.M005604200","article-title":"CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors.","volume":"275","author":"Evans","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.102.037754_bib10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1139\/y95-152","article-title":"Clinical perspectives of calcitonin gene related peptide pharmacology.","volume":"73","author":"Feuerstein","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/jpet.102.037754_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0165-6147(99)01347-4","article-title":"RAMPs: accessory proteins for seven transmembrane domain receptors.","volume":"20","author":"Foord","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.102.037754_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1476-5381.1992.tb12775.x","article-title":"Involvement of multiple receptors in the biological effects of calcitonin gene-related peptide and amylin in rat and guinea-pig preparations.","volume":"107","author":"Giuliani","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.037754_bib13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.RES.73.3.579","article-title":"Peptidergic innervation of human epicardial coronary arteries.","volume":"73","author":"Gulbenkian","year":"1993","journal-title":"Circ Res"},{"key":"10.1124\/jpet.102.037754_bib14","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/sj.bjp.0704210","article-title":"CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with \u201cCompound 1\u201d (WO98\/11128), a non-peptide antagonist.","volume":"133","author":"Hasbak","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.037754_bib15","first-page":"138","article-title":"Adrenomedullin, a multifunctional regulatory peptide.","volume":"21","author":"Hinson","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.102.037754_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/heart.84.1.88","article-title":"Decreased adrenomedullin production in the coronary circulation of patients with coronary artery disease.","volume":"84","author":"Hojo","year":"2000","journal-title":"Heart"},{"key":"10.1124\/jpet.102.037754_bib17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0165-6147(00)01555-8","article-title":"The molecular pharmacology of CGRP and related peptide receptor subtypes.","volume":"21","author":"Juaneda","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.102.037754_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004872-199602000-00009","article-title":"Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells.","volume":"14","author":"Kano","year":"1996","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.102.037754_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","article-title":"Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.","volume":"192","author":"Kitamura","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.102.037754_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003495-199549040-00001","article-title":"Adrenomedullin. Implications for hypertension research.","volume":"49","author":"Kitamura","year":"1995","journal-title":"Drugs"},{"key":"10.1124\/jpet.102.037754_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(94)90222-4","article-title":"Effects of two truncated forms of human calcitonin-gene related peptide: implications for receptor classification.","volume":"265","author":"Longmore","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.037754_bib22","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.93.8.3455","article-title":"Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay.","volume":"93","author":"Luebke","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.102.037754_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature (Lond)"},{"key":"10.1124\/jpet.102.037754_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/308746a0","article-title":"Isolation and characterization of human calcitonin gene-related peptide.","volume":"308","author":"Morris","year":"1984","journal-title":"Nature (Lond)"},{"key":"10.1124\/jpet.102.037754_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ Res"},{"key":"10.1124\/jpet.102.037754_bib26","first-page":"H2574","article-title":"Cardiovascular actions of adrenomedullin in conscious sheep.","volume":"268","author":"Parkes","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.102.037754_bib27","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0022-3565(24)29232-6","article-title":"Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.","volume":"299","author":"Rorabaugh","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.102.037754_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0773.1996.tb00217.x","article-title":"Effect of parasympathetic and sensory transmitters on human epicardial coronary arteries and veins.","volume":"78","author":"Saetrum","year":"1996","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/jpet.102.037754_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0014-2999(00)00233-8","article-title":"Positive inotropy mediated via CGRP receptors in isolated human myocardial trabeculae.","volume":"397","author":"Saetrum","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.102.037754_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3940(98)00844-1","article-title":"Expression of calcitonin receptor-like receptor and receptor-activity- modifying proteins in human cranial arteries.","volume":"258","author":"Sams","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.102.037754_bib31","first-page":"440","article-title":"Recent advances in our understanding of peptide hormone receptors and RAMPs.","volume":"2","author":"Sexton","year":"1999","journal-title":"Curr Opin Drug Discov Dev"},{"key":"10.1124\/jpet.102.037754_bib32","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/sj.bjp.0701760","article-title":"Characterization of calcitonin gene-related peptide (CGRP) receptors in intramural coronary arteries from male and female Sprague Dawley rats.","volume":"123","author":"Sheykhzade","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.102.037754_bib33","doi-asserted-by":"crossref","first-page":"H2620","DOI":"10.1152\/ajpheart.2000.279.6.H2620","article-title":"Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels.","volume":"279","author":"Terata","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.102.037754_bib34","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cvr\/27.8.1477","article-title":"Effect of intravenous calcitonin gene related peptide on ischaemia threshold and coronary stenosis severity in humans.","volume":"27","author":"Uren","year":"1993","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.102.037754_bib35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0022-3565(24)38288-6","article-title":"Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors.","volume":"289","author":"Waugh","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"year":"1971","series-title":"Statistical Principles in Experimental Design","author":"Winer","key":"10.1124\/jpet.102.037754_bib36"},{"key":"10.1124\/jpet.102.037754_bib37","first-page":"2","article-title":"Recommendations guiding physicians in biomedical research involving human subjects.","volume":"35","year":"1997","journal-title":"Cardiovasc Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524361154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524361154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.102.037754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:34:40Z","timestamp":1740008080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524361154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0022356524361154"],"URL":"https:\/\/doi.org\/10.1124\/jpet.102.037754","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of CGRP Receptors and Peptide Pharmacology in Human Coronary Arteries. Characterization with a Nonpeptide Antagonist","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.102.037754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}